SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Clinical trial NCT05445154 · RECRUITING
Trial details
- NCT number
- NCT05445154
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2024-10-31
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.